ERBB3 and familial pancreatic carcinoma: Given the hypothesis that HER3 expression after chemotherapy may be different from that previously reported at the time of diagnosis, we investigated the status of HER3 expression after chemotherapy for pancreatic cancer and evaluated the associations among HER3 expression, clinicopathological features, and patient clinical outcomes.